Lead sponsor
Ariel University
1 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 6, 2026.
1
Trials led
1
Ongoing
120
Total enrollment
3
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Not applicable
1
Trials by status
Recruiting
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Nutritional Therapy to Incretin-based Anti-obesity Medications in the Management of Gastrointestinal Adverse EventsBMI ≥30not applicableRecruiting120